Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.17 EUR | +0.33% | +8.25% | -7.08% |
May. 22 | Nanobiotix: strategy update, share price declines | CF |
May. 21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
315M | - | |||||
58.71B | - | |||||
41.31B | ||||||
39.2B | ||||||
27.4B | ||||||
26.55B |
- Stock Market
- Equities
- NANO Stock
- Charts Nanobiotix
- Sector Chart